Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia.

Sherbenou DW, Hantschel O, Turaga L, Kaupe I, Willis S, Bumm T, Press RD, Superti-Furga G, Druker BJ, Deininger MW. Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia. Leukemia. 2008 Jun; 22(6):1184-90.

View in: PubMed

subject areas

Adult
Aged
Benzamides
Cell Proliferation
Cells, Cultured
Drug Resistance, Neoplasm
Female
Follow-Up Studies
Fusion Proteins, bcr-abl
Humans
Imatinib Mesylate
Immunoblotting
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Male
Middle Aged
Mutation
Phosphorylation
Piperazines
Precursor Cells, B-Lymphoid
Protein Conformation
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Pyrimidines
Sequence Deletion
Tyrosine

authors with profiles

Daniel W Sherbenou